Modernising AI Medical Devices Regulation: FDA&...

By Danélia Botes

July 26, 2024

Introduction The regulation of artificial intelligence (AI) medical devices has become a pressing issue. The US Food and Drug Administration (FDA) has adopted a firm-based approach for regulating lower-risk

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

JOIN NEWSLETTER




SERVICES

© 2024 Syenza™. All rights reserved.